[Billing Code: 4140-01-P]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby
given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions
could disclose confidential trade secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel High Priority
HIV and Substance Use Research
Date: July 11, 2024
Time: 10:00 AM to 5:00 PM
Agenda: To review and evaluate grant applications
Place: National Institute of Health
National Institute on Drug Abuse
301 North Stonestreet Avenue
Bethesda, MD 20892
(Virtual Meeting)
Contact Person: Trinh T. Tran, Ph.D.
Scientific Review Officer
Scientific Review Branch
Office of Extramural Policy
National Institute on Drug Abuse, NIH

301 North Stonestreet Avenue, MSC 6021
Bethesda, MD 20892
(301) 827-5843
trinh.tran@nih.gov
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Cutting-Edge
Basic Research Awards (CEBRA)
Date: July 16, 2024
Time: 10:00 AM to 6:00 PM
Agenda: To review and evaluate grant applications
Place: National Institute of Health
National Institute on Drug Abuse
301 North Stonestreet Avenue
Bethesda, MD 20892
(Virtual Meeting)
Contact Person: Sheila Pirooznia, Ph.D.
Scientific Review Officer
Division of Extramural Review
Scientific Review Branch
National Institute on Drug Abuse, NIH
301 North Stonestreet Avenue, MSC 6021
Bethesda, MD 20892
(301) 496-9350
sheila.pirooznia@nih.gov
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Psychedelics
Treatment Research in Substance Use Disorder
Date: July 16, 2024

Time: 11:00 AM to 4:00 PM
Agenda: To review and evaluate grant applications
Place: National Institute of Health
National Institute on Drug Abuse
301 North Stonestreet Avenue
Bethesda, MD 20892
(Virtual Meeting)
Contact Person: Soyoun Cho, Ph.D.
Scientific Review Officer
Scientific Review Branch
Division of Extramural Research
National Institute on Drug Abuse, NIH
301 North Stonestreet Avenue, MSC 6021
Bethesda, MD 20892
(301) 594-9460
Soyoun.cho@nih.gov
Contact Person: Brian Stefan Wolff, Ph.D.
Scientific Review Officer
Scientific Review Branch
Division of Extramural Research
National Institute on Drug Abuse, NIH
301 North Stonestreet Avenue, MSC 6021
Bethesda, MD 20892
(301) 480-1448
brian.wolff@nih.gov

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279,
Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)
Dated: June 7, 2024.
Lauren A. Fleck,
Program Analyst,
Office of Federal Advisory Committee Policy.
[FR Doc. 2024-12990 Filed: 6/12/2024 8:45 am; Publication Date: 6/13/2024]